IVERMECTIN

Post-LOE

ivermectin

ANDAORALTABLET
Approved
Oct 2014
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
6

Mechanism of Action

CLINICAL PHARMACOLOGY Pharmacokinetics Following oral administration of ivermectin, plasma concentrations are approximately proportional to the dose. In two studies, after single 12-mg doses of ivermectin tablets in fasting healthy volunteers (representing a mean dose of 165 mcg/kg), the mean peak…

Pharmacologic Class:

Antiparasitic

Clinical Trials (5)

NCT03301649Phase 3Completed

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Started Oct 2017
905 enrolled
Head Lice
NCT03286101Phase 2Completed

Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos

Started Sep 2017
120 enrolled
Pediculosis Capitis
NCT00921219Phase 1Completed

Ivermectin Solution Bioequivalence Study - With Food (Repeat)

Started Sep 2005
34 enrolled
Healthy
NCT00921154Phase 1Completed

Ivermectin Solution Bioequivalence Study - Fasted

Started Mar 2005
24 enrolled
Healthy
NCT00921674Phase 1Completed

Ivermectin Solution Bioequivalence Study - With Food

Started Feb 2005
24 enrolled
Healthy